13G - INDIVIOR PLC

Company

Indivior Pharmaceuticals, Inc.

Filed

April 9, 2024

Accession Number

0001313360-24-000005

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →